Zevra Therapeutics, Inc. (ZVRA) — DEF 14A Filings
All DEF 14A filings from Zevra Therapeutics, Inc.. Browse 1 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (1)
-
Zevra Therapeutics Files DEF 14A for FY2023
— Apr 3, 2024 Risk: medium
Zevra Therapeutics, Inc. (formerly KemPharm, Inc.) filed a DEF 14A with the SEC on April 3, 2024, for the fiscal year ending December 31, 2023. The filing detai
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX